Common GLP-1 receptor agonist medications include semaglutide drugs such as Ozempic, Wegovy, and Rybelsus, as well as tirzepatide medications including Mounjaro and Zepbound
Type 2 Diabetes (T2D) formerly regarded as a disorder of middle and late adulthood-is now diagnosed with increasing frequency among both adolescents and young adults, resulting in prolonged exposure to hyperglycemia, insulin resistance, and attendant morbidities [2]
Results May Vary Individual results will vary based on factors including age, baseline weight, metabolic health, consistency of medication use, lifestyle factors (diet, physical activity, sleep), genetic factors, current medications, and other individual variables
SURPASS-4, a cardiovascular safety study in 2,002 patients with type 2 diabetes and increased cardiovascular risk, demonstrated blood pressure changes over 104 weeks
This guide compares the leading telehealth providers offering Tirzepatide, detailing their pricing models, perks, and other key factors
